$1.370
-0.048 (-3.52%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de CHRS por análisis de gráficos similares
Alphio's CHRS stock price prediction model matches the current Coherus Oncology Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $1.39 (+1.21%). The 1-week path is $1.22 (-10.59%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de Coherus Oncology Inc?
Coherus BioSciences Inc appears to be a good buy right now due to its current price of $1.41, which is significantly lower than the analyst price target of $10, suggesting a potential upside of 607%. Additionally, the company has shown a strong gross margin of 70.35% in Q2 2026, indicating effective cost management and profitability potential. However, investors should be cautious of the high forward P/E ratio of 41.15, which suggests that the stock may be overvalued based on future earnings expectations.
CHRS cerró en $1.37 el Thursday, tras bajar -3.52%
Coherus Oncology Inc (CHRS) last closed at $1.37, losing -3.52%. These facts feed the 1-day and 1-week CHRS price prediction above.
Consenso de analistas
Coherus Oncology Inc (CHRS): 8 comprar, 0 mantener, 0 vender. Perspectiva: Strong Buy.
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
Factores de la previsión
Los factores de la previsión de Coherus Oncology Inc (CHRS) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bearish
Seasonality
Bearish
SMA 20
Bullish
SMA 200
Bearish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de CHRS, ordenadas por similitud.
Análisis de estacionalidad de CHRS
Historically the probability of a positive September return for CHRS is 22.73%. October offers the highest probability of a positive month at 50.00%, while December is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Proyecciones de precio a 10 años de CHRS
| Mes | Precio mínimo | Precio medio | Precio máximo | ROI potencial |
|---|---|---|---|---|
| Sep 2026 | $0.46 | $0.61 | $0.72 | -55.55% |
| Oct 2026 | $0.65 | $0.74 | $0.90 | -46.27% |
| Nov 2026 | $0.63 | $0.65 | $0.72 | -52.91% |
| Dec 2026 | $0.58 | $0.70 | $0.75 | -48.75% |
En 2026, se proyecta que Coherus Oncology Inc (CHRS) oscile entre $0.46 y $0.90.
Previsión mensual de Coherus Oncology Inc para 2026
En Sep de 2026, se proyecta que Coherus Oncology Inc promedie $0.61, con un mínimo de $0.46 y un máximo de $0.72.
En Oct de 2026, se proyecta que Coherus Oncology Inc promedie $0.74, con un mínimo de $0.65 y un máximo de $0.90.
En Nov de 2026, se proyecta que Coherus Oncology Inc promedie $0.65, con un mínimo de $0.63 y un máximo de $0.72.
En Dec de 2026, se proyecta que Coherus Oncology Inc promedie $0.70, con un mínimo de $0.58 y un máximo de $0.75.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.